Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose is to determine the effective dosage and to study the effects of this dosage taken for 12 days on systolic and diastolic blood pressure in patients with hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kadmon Corporation, LLC

Criteria

Inclusion Criteria:

• Male or females between 18 and 80 years, inclusive

• Moderate to severe hypertension

• Body weight within a body mass index range of 18 - 32 kg/m2

Exclusion Criteria:

• Subject is receiving more than four antihypertensive agents

• History of drug abuse

• Exposure to a new chemical entity within 3 months prior to the first day of dosing